# Aligos Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 16:00 ET
- Period: 2024-06-27
- Accession: 0001193125-24-122181
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524122181/d874273ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312524122181/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312524122181/d874273ddef14a.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-122181. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
